Nothing Special   »   [go: up one dir, main page]

"Toxicity risks evaluation of unknown FDA biotransformed drugs based on a ..."

Mohamed Abd El Aziz et al. (2020)

Details and statistics

DOI: 10.1016/J.ASOC.2019.105509

access: closed

type: Journal Article

metadata version: 2021-10-14